Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | IL6ST | P40189 | 1/20 | 0.33 |
| ▸ | ACE | P12821 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21075769 | 0.84 | MAPK1 (0.36) | NAAAIL6STACE | |
| SCHEMBL19083744 | 0.84 | MAPK1 (0.36) | NAAAIL6STACE | |
| SCHEMBL19083745 | 0.80 | NAAA (0.33) | NAAAIL6STACE | |
| SCHEMBL19084016 | 0.80 | IL6ST (0.43) | NAAAIL6STACE | |
| SCHEMBL7484640 | 0.75 | P2RX7 (0.39) | NAAAACE | |
| SCHEMBL3333540 | 0.75 | P2RX7 (0.39) | NAAAACE | |
| SCHEMBL22708254 | 0.75 | P2RX7 (0.39) | NAAAACE | |
| SCHEMBL1456292 | 0.75 | NAAA (0.33) | NAAAIL6ST | |
| SCHEMBL17428803 | 0.72 | KMT2A (0.33) | — | |
| SCHEMBL21802037 | 0.72 | AGTR2 (0.32) | ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110727-A1 | Aldehyde-releasing compounds | LA TROBE UNIVERSITY (AU) | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110727-A1 | Aldehyde-releasing compounds | AOX1, ALDH2, ACADM | NAAA 2678/4885IL6ST 3386/4885ACE 1900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.